Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment

Jemal, 2005, Cancer statistics, 2005, CA Cancer J Clin, 55, 10, 10.3322/canjclin.55.1.10

Hayat, 2007, Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program, Oncologist, 12, 20, 10.1634/theoncologist.12-1-20

Shiboski, 2005, Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years, Cancer, 103, 1843, 10.1002/cncr.20998

Gillison, 2000, Evidence for a causal association between human papillomavirus and a subset of head and neck cancers, J Natl Cancer Inst, 92, 709, 10.1093/jnci/92.9.709

Goldenberg, 2004, Habitual risk factors for head and neck cancer, Otolaryngol Head Neck Surg, 131, 986, 10.1016/j.otohns.2004.02.035

Zhang, 2000, Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma, Cancer Epidemiol Biomarkers Prev, 9, 1043

Lee, 2003, The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan, Br J Cancer, 88, 366, 10.1038/sj.bjc.6600727

Larsson, 1975, Relationship of Plummer-Vinson disease to cancer of the upper alimentary tract in Sweden, Cancer Res, 35, 3308

Wahlberg, 1998, Carcinoma of the hypopharynx: analysis of incidence and survival in Sweden over a 30-year period, Head Neck, 20, 714, 10.1002/(SICI)1097-0347(199812)20:8<714::AID-HED9>3.0.CO;2-2

Goldenberg, 2004, Epstein-Barr virus in head and neck cancer assessed by quantitative polymerase chain reaction, Laryngoscope, 114, 1027, 10.1097/00005537-200406000-00013

Shi, 2002, Molecular pathology parameters in human nasopharyngeal carcinoma, Cancer, 94, 1997, 10.1002/cncr.0679

Kreimer, 2005, Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review, Cancer Epidemiol Biomarkers Prev, 14, 467, 10.1158/1055-9965.EPI-04-0551

Gillison, 2004, Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity, Semin Oncol, 31, 744, 10.1053/j.seminoncol.2004.09.011

D'Souza, 2007, Case-control study of human papillomavirus and oropharyngeal cancer, N Engl J Med, 356, 1944, 10.1056/NEJMoa065497

Chaturvedi, 2008, Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States, J Clin Oncol, 26, 612, 10.1200/JCO.2007.14.1713

Herrero, 2003, Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study, J Natl Cancer Inst, 95, 1772, 10.1093/jnci/djg107

Hayes, 1986, Wood-related occupations, wood dust exposure, and sinonasal cancer, Am J Epidemiol, 124, 569, 10.1093/oxfordjournals.aje.a114429

Hernberg, 1983, Nasal and sinonasal cancer: connection with occupational exposures in Denmark, Finland and Sweden, Scand J Work Environ Health, 9, 315, 10.5271/sjweh.2405

Sidransky, 1995, Molecular genetics of head and neck cancer, Curr Opin Oncol, 7, 229, 10.1097/00001622-199505000-00007

Forastiere, 2001, Head and neck cancer, N Engl J Med, 345, 1890, 10.1056/NEJMra001375

Brennan, 1996, Molecular staging of head and neck squamous carcinoma, Cancer Metastasis Rev, 15, 3, 10.1007/BF00049484

Brennan, 1995, Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck, N Engl J Med, 332, 712, 10.1056/NEJM199503163321104

Poeta, 2007, TP53 mutations and survival in squamous-cell carcinoma of the head and neck, N Engl J Med, 357, 2552, 10.1056/NEJMoa073770

Reed, 1996, High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma, Cancer Res, 56, 3630

Kalyankrishna, 2006, Epidermal growth factor receptor biology in head and neck cancer, J Clin Oncol, 24, 2666, 10.1200/JCO.2005.04.8306

Chung, 2007, Gene expression profiles as markers of aggressive disease-EGFR as a factor, Int J Radiat Oncol Biol Phys, 69, S102, 10.1016/j.ijrobp.2007.05.039

Sok, 2006, Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting, Clin Cancer Res, 12, 5064, 10.1158/1078-0432.CCR-06-0913

Suen, 1996, Cancer of the head and neck, 462

Stoeckli, 2001, Role of routine panendoscopy in cancer of the upper aerodigestive tract, Otolaryngol Head Neck Surg, 124, 208, 10.1067/mhn.2001.112311

Guardiola, 2006, Is there still a role for triple endoscopy as part of staging for head and neck cancer?, Curr Opin Otolaryngol Head Neck Surg, 14, 85

van den Brekel, 1994, The role of modern imaging studies in staging and therapy of head and neck neoplasms, Semin Oncol, 21, 340

Baker, 1986, Magnetic resonance imaging of the head and neck, Otolaryngol Head Neck Surg, 95, 82, 10.1177/019459988609500116

Dammann, 2005, Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET, AJR Am J Roentgenol, 184, 1326, 10.2214/ajr.184.4.01841326

McGuirt, 1998, PET scanning in head and neck oncology: a review, Head Neck, 20, 208, 10.1002/(SICI)1097-0347(199805)20:3<208::AID-HED5>3.0.CO;2-4

Adams, 1998, Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer, Eur J Nucl Med, 25, 1255, 10.1007/s002590050293

Ha, 2006, The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma, Arch Otolaryngol Head Neck Surg, 132, 12, 10.1001/archotol.132.1.12

Fischbein, 1998, Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck, AJNR Am J Neuroradiol, 19, 1189

Greene, 2002, 435

Department of Veterans Affairs Laryngeal Cancer Study Group, 1991, Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer, N Engl J Med, 324, 1685, 10.1056/NEJM199106133242402

Al-Sarraf, 1998, Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099, J Clin Oncol, 16, 1310, 10.1200/JCO.1998.16.4.1310

Forastiere, 2006, Long-term results of Intergroup RTOG 91-11: a phase III trial to preserve the larynx—induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy [abstract 5517], J Clin Oncol, 24, 18s, 10.1200/jco.2006.24.18_suppl.5517

Forastiere, 2003, Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer, N Engl J Med, 349, 2091, 10.1056/NEJMoa031317

2006, 1

Bonner, 2006, Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck, N Engl J Med, 354, 567, 10.1056/NEJMoa053422

Posner, 2007, Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer, N Engl J Med, 357, 1705, 10.1056/NEJMoa070956

Vermorken, 2007, Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer, N Engl J Med, 357, 1695, 10.1056/NEJMoa071028

Remenar, 2006, J Clin Oncol, 24, 81S, 10.1200/jco.2006.24.18_suppl.5516

Hu, 2005, Brachytherapy versus intensity-modulated radiation therapy in the management of base of tongue cancers, Brachytherapy, 4, 1, 10.1016/j.brachy.2004.10.002

Adelstein, 2003, An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer, J Clin Oncol, 21, 92, 10.1200/JCO.2003.01.008

Calais, 1999, Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma, J Natl Cancer Inst, 91, 2081, 10.1093/jnci/91.24.2081

Denis, 2004, Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma, J Clin Oncol, 22, 69, 10.1200/JCO.2004.08.021

Bensadoun, 2006, French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC), Int J Radiat Oncol Biol Phys, 64, 983, 10.1016/j.ijrobp.2005.09.041

Keane, 1982, Carcinoma of the hypopharynx, J Otolaryngol, 11, 227

Amdur, 2001, Organ preservation with radiotherapy for T1-T2 carcinoma of the pyriform sinus, Head Neck, 23, 353, 10.1002/hed.1044

Lefebvre, 1996, Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial, J Natl Cancer Inst, 88, 890, 10.1093/jnci/88.13.890

Pfister, 2006, American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer, J Clin Oncol, 24, 3693, 10.1200/JCO.2006.07.4559

Wei, 2005, Nasopharyngeal carcinoma, Lancet, 365, 2041, 10.1016/S0140-6736(05)66698-6

Baujat, 2006, Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients, Int J Radiat Oncol Biol Phys, 64, 47, 10.1016/j.ijrobp.2005.06.037

Rusthoven, 2004, The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor, Cancer, 101, 2641, 10.1002/cncr.20687

Colletier, 1998, Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure, Head Neck, 20, 674, 10.1002/(SICI)1097-0347(199812)20:8<674::AID-HED3>3.0.CO;2-H

Erkal, 2001, Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head-and-neck mucosal site treated with radiation therapy alone or in combination with neck dissection, Int J Radiat Oncol Biol Phys, 50, 55, 10.1016/S0360-3016(00)01554-6

de Braud, 1989, Metastatic squamous cell carcinoma of an unknown primary localized to the neck: advantages of an aggressive treatment, Cancer, 64, 510, 10.1002/1097-0142(19890715)64:2<510::AID-CNCR2820640225>3.0.CO;2-2

Jeremic, 1992, Radiotherapy and cisplatin in metastatic squamous cell carcinoma of an unknown primary tumor localized to the neck: a phase II study, J Chemother, 4, 399, 10.1080/1120009X.1992.11739199

Colevas, 2006, Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck, J Clin Oncol, 24, 2644, 10.1200/JCO.2005.05.3348

Forastiere, 1992, Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study, J Clin Oncol, 10, 1245, 10.1200/JCO.1992.10.8.1245

Jacobs, 1992, A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck, J Clin Oncol, 10, 257, 10.1200/JCO.1992.10.2.257

Trigo, 2004, Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN): results of phase II study [abstract 5502], J Clin Oncol, 22, 14S, 10.1200/jco.2004.22.14_suppl.5502

Herbst, 2005, Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck, J Clin Oncol, 23, 5578, 10.1200/JCO.2005.07.120

Baselga, 2005, J Clin Oncol, 23, 5568, 10.1200/JCO.2005.07.119

Burtness, 2005, Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study, J Clin Oncol, 23, 8646, 10.1200/JCO.2005.02.4646

BVermorken J, Mesia R, Vega V, et al. Cetuximab extends survival of patients with recurrent or metastatic SCCHN when added to first line platinum based therapy—results of a randomized phase III (Extreme) study [abstract 6091]. 2007 ASCO Annual Meeting, Chicago, IL; Jun 1-5, 2007.

Bernier, 2004, Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer, N Engl J Med, 350, 1945, 10.1056/NEJMoa032641

Cooper, 2004, Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck, N Engl J Med, 350, 1937, 10.1056/NEJMoa032646

Bernier, 2005, Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501), Head Neck, 27, 843, 10.1002/hed.20279

Cooper, 2006, Long-term survival results of a phase III intergroup trial (RTOG 95-01) of surgery followed by radiotherapy vs. radiochemotherapy for resectable high risk squamous cell carcinoma of the Head and Neck [abstract 25], Int J Radiat Oncol Biol Phys, 66, S14, 10.1016/j.ijrobp.2006.07.1338